You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis
M. M. Ipp, L. Boxall and E. W. Gelfand
Long-term intermittent therapy with the orally administered antifungal
agent, clotrimazole, has not been reported previously. On the basis of
experiences with our patient we propose that this is an effective way of
treating chronic mucocutaneous candidiasis with a minimum of side effects.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Emergence of Resistance of Candida albicans to Clotrimazole in Human Immunodeficiency Virus-Infected Children: In Vitro and Clinical Correlations
Pelletier et al. J. Clin. Microbiol. 2000;38:1563-1568. ABSTRACT
| FULL TEXT
